Physician profile
Daniel P Klein
NPI 1306924519
$804.74
in general payments reported to CMS, 2019-2025
9 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.32 · 2020: $25.89 · 2021: $124 · 2022: $45.18 · 2023: $15.44 · 2024: $197 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $461.78 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Stryker Corporation | $173.05 | 2025 | Flowtriever |
| Lilly USA, LLC | $38.61 | 2024 | Omvoh |
| Novo Nordisk INC | $38.58 | 2019-2025 | |
| Ethicon US, LLC | $25.89 | 2020 | |
| Allergan, INC. | $19.01 | 2019 | |
| Seqirus USA INC | $17.50 | 2024 | Flucelvax, Fluad |
| E.R. Squibb & Sons, L.L.C. | $15.44 | 2023 | Eliquis |
| Pfizer INC. | $14.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.